AT322551B - Verfahren zur herstellung neuer 2,4,5-trisubstituierter oxazole - Google Patents

Verfahren zur herstellung neuer 2,4,5-trisubstituierter oxazole

Info

Publication number
AT322551B
AT322551B AT3673A AT3673A AT322551B AT 322551 B AT322551 B AT 322551B AT 3673 A AT3673 A AT 3673A AT 3673 A AT3673 A AT 3673A AT 322551 B AT322551 B AT 322551B
Authority
AT
Austria
Prior art keywords
preparing new
oxazoles
trisubstituted
trisubstituted oxazoles
preparing
Prior art date
Application number
AT3673A
Other languages
German (de)
English (en)
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of AT322551B publication Critical patent/AT322551B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT3673A 1972-08-07 1973-01-02 Verfahren zur herstellung neuer 2,4,5-trisubstituierter oxazole AT322551B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2795872 1972-08-07

Publications (1)

Publication Number Publication Date
AT322551B true AT322551B (de) 1975-05-26

Family

ID=11222675

Family Applications (1)

Application Number Title Priority Date Filing Date
AT3673A AT322551B (de) 1972-08-07 1973-01-02 Verfahren zur herstellung neuer 2,4,5-trisubstituierter oxazole

Country Status (23)

Country Link
JP (1) JPS5030619B2 (xx)
KR (1) KR780000069B1 (xx)
AR (1) AR200007A1 (xx)
AT (1) AT322551B (xx)
AU (1) AU477231B2 (xx)
BE (1) BE794096A (xx)
CH (1) CH544105A (xx)
CS (1) CS177127B2 (xx)
DD (1) DD106387A5 (xx)
DE (1) DE2301030A1 (xx)
ES (1) ES417638A1 (xx)
FR (1) FR2195430B1 (xx)
GB (1) GB1374345A (xx)
HU (1) HU164781B (xx)
IE (1) IE36941B1 (xx)
IL (1) IL40904A (xx)
LU (1) LU66643A1 (xx)
NL (1) NL149797B (xx)
NO (1) NO137550C (xx)
RO (1) RO63442A (xx)
SE (1) SE376236B (xx)
SU (1) SU511003A3 (xx)
ZA (1) ZA728259B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0167973A1 (de) * 1984-07-07 1986-01-15 Roche Diagnostics GmbH Redox-Indikatoren

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD112905A5 (xx) * 1971-09-02 1975-05-12 Snam Progetti
US4110256A (en) * 1976-06-22 1978-08-29 Nippon Soken, Inc. Catalyst for reforming fuel and method for producing same
JPS59125900U (ja) * 1983-02-10 1984-08-24 マルヤス機械株式会社 組立ライン装置
JPS6133499U (ja) * 1984-07-30 1986-02-28 中西金属工業株式会社 電気製品製造用パレツト
ES2144403T3 (es) * 1990-11-30 2000-06-16 Otsuka Pharma Co Ltd Derivados de tiazol como inhibidores de oxigeno activo.
GB0709031D0 (en) 2007-05-10 2007-06-20 Sareum Ltd Pharmaceutical compounds
US8946231B2 (en) 2009-03-23 2015-02-03 Merck Sharp & Dohme Corp. P2X3, receptor antagonists for treatment of pain
GB201202027D0 (en) 2012-02-06 2012-03-21 Sareum Ltd Pharmaceutical compounds
US20130231340A1 (en) 2012-03-02 2013-09-05 Sareum Limited Pharmaceutical compounds
GB201617871D0 (en) 2016-10-21 2016-12-07 Sareum Limited Pharmaceutical compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1226548A (xx) * 1967-06-14 1971-03-31 Wyeth John & Brother Ltd

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0167973A1 (de) * 1984-07-07 1986-01-15 Roche Diagnostics GmbH Redox-Indikatoren

Also Published As

Publication number Publication date
RO63442A (fr) 1978-07-15
JPS5030619B2 (xx) 1975-10-02
SE376236B (xx) 1975-05-12
IE36941B1 (en) 1977-03-30
IE36941L (en) 1974-02-07
AR200007A1 (es) 1974-10-15
DE2301030A1 (de) 1974-02-28
AU5698273A (en) 1974-12-19
AU477231B2 (en) 1976-10-21
IL40904A0 (en) 1973-01-30
ZA728259B (en) 1973-07-25
CH544105A (fr) 1973-11-15
FR2195430B1 (xx) 1976-04-09
IL40904A (en) 1975-12-31
NL7300326A (xx) 1974-02-11
KR780000069B1 (en) 1978-03-30
SU511003A3 (ru) 1976-04-15
NL149797B (nl) 1976-06-15
JPS4945067A (xx) 1974-04-27
DD106387A5 (xx) 1974-06-12
BE794096A (fr) 1973-05-16
HU164781B (xx) 1974-04-11
ES417638A1 (es) 1976-02-01
NO137550C (no) 1978-03-15
CS177127B2 (xx) 1977-07-29
FR2195430A1 (xx) 1974-03-08
LU66643A1 (xx) 1973-02-14
NO137550B (no) 1977-12-05
GB1374345A (en) 1974-11-20

Similar Documents

Publication Publication Date Title
AT328447B (de) Verfahren zur herstellung neuer 1,4-dihydropyridine
CH542232A (de) Verfahren zur Herstellung neuer 1,2,4-Oxadiazol-Derivate
AT333752B (de) Verfahren zur herstellung neuer benzoxazol-derivate
DD110652A5 (de) Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkinylaminopropane
AT333987B (de) Verfahren zur herstellung neuer insulinderivate
AT322551B (de) Verfahren zur herstellung neuer 2,4,5-trisubstituierter oxazole
CH556351A (de) Verfahren zur herstellung neuer trisubstituierter oxazole.
AT324309B (de) Verfahren zur herstellung neuer 2-aminoalkanoylaminobenzophenone
CH555798A (de) Verfahren zur herstellung neuer 1,1-diphenyl-2-nitropropanderivate.
AT329041B (de) Verfahren zur herstellung neuer 2-(n-phenyl-n- (r1,r2-aminoalkyl) )-amino- (1,2,3,4-tetrahydronaphthaline)
CH556835A (de) Verfahren zur herstellung neuer spiroindanpyrrolidinderivate.
CH520156A (de) Verfahren zur Herstellung neuer Perhydro-5-phenylcyclo-alkapolyen-1,4-oxazepine
AT326120B (de) Verfahren zur herstellung neuer isoxazolidinderivate
AT332001B (de) Verfahren zur herstellung der neuen 20beta-hydroxy-9-oxo- 1,2,3,4,10,19 -hexanor-5,9-seco-pregnan-5-saure
AT336603B (de) Verfahren zur herstellung neuer oxazolidine
AT340396B (de) Verfahren zur herstellung neuer substituierter chloracetanilide
ATA304275A (de) Verfahren zur herstellung neuer benzoxazol-derivate
ATA304175A (de) Verfahren zur herstellung neuer benzoxazol-derivate
ATA177175A (de) Verfahren zur herstellung neuer 1,4-dihydropyridine
CH546240A (de) Verfahren zur herstellung neuer indenopyridinderivate.
AT332417B (de) Verfahren zur herstellung neuer 1,2,4- benztriazin -1,4-di-n- oxidderivate
AT325595B (de) Verfahren zur herstellung des neuen 1,3,3-trimethyl-1-octylaminomethyl-5-octylamino-cyclohexans
ATA328274A (de) Verfahren zur herstellung neuer substituierter chloracetanilide
ATA814773A (de) Verfahren zur herstellung des neuen 1,3,3-trimethyl-1-dodecylaminomethyl-5-aminocyclohexans
ATA393575A (de) Verfahren zur herstellung neuer 5-(4-(alkylthioalkoxyphenoxy)-methyl)-oxazolidinone

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee